Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


1 J Infect
1 J Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 Nat Immunol
3 Pediatr Infect Dis J
12 PLoS One
1 Science
15 Vaccine
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


    Pregnant women and older adults in England and Scotland to be offered RSV vaccination.
    BMJ. 2024;385:q1436.

    J Infect

  2. GONG X, Peng L, Wang F, Liu J, et al
    Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants.
    J Infect. 2024;89:106208.
    PubMed         Abstract available

    J Infect Dis

  3. ANANWORANICH J, Lee IT, Ensz D, Carmona L, et al
    Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial.
    J Infect Dis. 2024 Jun 27:jiae329. doi: 10.1093.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  4. MENDES A, Mohamed GA, Derow M, Stehling-Ariza T, et al
    Persistent Transmission of Circulating Vaccine-Derived Poliovirus - Somalia, January 2017-March 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:575-580.
    PubMed         Abstract available

    Nat Immunol

  5. Vaccination prevents cognitive impairment after breakthrough infection with SARS-CoV-2.
    Nat Immunol. 2024 Jun 25. doi: 10.1038/s41590-024-01869.

    Pediatr Infect Dis J

  6. SOONTHORNARRAK K, Limrungsikul A, Apiwattanakul N
    Comparison of Hepatitis B Surface Antibody Levels After Vaccination With Combined One Dose of Hexavalent Vaccine and Two Doses of Pentavalent Vaccine Versus Three Doses of Pentavalent Vaccine.
    Pediatr Infect Dis J. 2024 Jun 24. doi: 10.1097/INF.0000000000004449.
    PubMed         Abstract available

  7. DEMIRBUGA A, Keskindemir G, Onal Z, Dede E, et al
    Bacillus Calmette-Guerin Vaccine-associated Complications in Immunodeficient Patients Following Liver Transplantation.
    Pediatr Infect Dis J. 2024 Jun 25. doi: 10.1097/INF.0000000000004456.

  8. OLUWASEUN S, Cagnan L, Xausa I, Nachbar RB, et al
    Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France.
    Pediatr Infect Dis J. 2024 Jun 25. doi: 10.1097/INF.0000000000004448.
    PubMed         Abstract available

    PLoS One

  9. FERRIS BF, Balasubramanian S, Rajamanickam A, Munisankar S, et al
    Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India.
    PLoS One. 2024;19:e0305819.
    PubMed         Abstract available

  10. YU H, Bonett S, Oyiborhoro U, Aryal S, et al
    Psychosocial correlates of parents' willingness to vaccinate their children against COVID-19.
    PLoS One. 2024;19:e0305877.
    PubMed         Abstract available

  11. AKRONG GB, Hiadzi RA, Donkor AB, Anafo DK, et al
    COVID-19 vaccine acceptance and hesitancy in Ghana: A systematic review.
    PLoS One. 2024;19:e0305993.
    PubMed         Abstract available

  12. CARLOCK MA, Allen JD, Hanley HB, Ross TM, et al
    Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.
    PLoS One. 2024;19:e0301157.
    PubMed         Abstract available

  13. BOTELHO RO, Coelho CCF, Andrade EF, Castelo PM, et al
    Fear of the COVID-19 vaccine in a public healthcare system and university setting.
    PLoS One. 2024;19:e0304000.
    PubMed         Abstract available

  14. WERDIN S, Neufeind J
    The implementation of a new measles vaccine mandate in Germany: A qualitative study in local health departments.
    PLoS One. 2024;19:e0306003.
    PubMed         Abstract available

  15. DEBELLUT F, Friedrich A, Baral R, Pecenka C, et al
    The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature.
    PLoS One. 2024;19:e0305692.
    PubMed         Abstract available

  16. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
    Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
    PLoS One. 2024;19:e0306044.
    PubMed         Abstract available

  17. SAMMAN N, Mohabatkar H, Behbahani M, Ganjlikhani Hakemi M, et al
    Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35 epitopes against breast cancer and evaluation of its immunological function in BALB/c mouse model.
    PLoS One. 2024;19:e0306117.
    PubMed         Abstract available

  18. BARDACH A, Ruvinsky S, Palermo MC, Alconada T, et al
    Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis.
    PLoS One. 2024;19:e0304978.
    PubMed         Abstract available

  19. FARHAN M, Shah Z, Ling Z, Shah K, et al
    Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach.
    PLoS One. 2024;19:e0304375.
    PubMed         Abstract available

  20. GURAV YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, et al
    Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
    PLoS One. 2024;19:e0306293.
    PubMed         Abstract available


  21. LAXMINARAYAN R, Gleason A, Sheen J, Saad-Roy CM, et al
    Unlock the potential of vaccines in food-producing animals.
    Science. 2024;384:1409-1411.
    PubMed         Abstract available


  22. JIN F, Zhu L, Wang Y, Qin G, et al
    Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographic.
    Vaccine. 2024 Jun 26:S0264-410X(24)00700-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  23. GUTIERREZ MP, Huckaby AB, Yang E, Weaver KL, et al
    Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice.
    Vaccine. 2024 Jun 26:S0264-410X(24)00725-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  24. KELLY JA, Walsh JL, Quinn K, Amirkhanian YA, et al
    Factors predicting primary and booster COVID-19 vaccination in a community sample of African American men and women in the United States Midwest.
    Vaccine. 2024 Jun 27:S0264-410X(24)00729-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  25. COULIBALY D, Douba A, N'Guessan K, N'Gattia AK, et al
    Intent to receive flu vaccine and influenza vaccination coverage among health professionals during 2019, 2020 and 2021 campaigns in Cote d'Ivoire.
    Vaccine. 2024 Jun 25:S0264-410X(24)00717-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  26. YOO YM, Katz MA, Greenberg D, Marcenac P, et al
    Knowledge, attitudes, and practices associated with influenza vaccine uptake among healthcare personnel in Israel during three influenza seasons, 2016-2019.
    Vaccine. 2024 Jun 25:S0264-410X(24)00705-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  27. HUSSEIN I, Mohamud H, Hussein A, Luomala O, et al
    "If the nurse tells me this is a good thing, I trust her completely" - Exploring health system enablers of MMR vaccine uptake in the Finnish Somali community: A mixed method study.
    Vaccine. 2024 Jun 25:S0264-410X(24)00728-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  28. VIANNA CM, Noronha TG, Camacho LAB, Andrade RC, et al
    Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study - A complementary study.
    Vaccine. 2024 Jun 25:S0264-410X(24)00724-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  29. CHATZILENA A, Hyams C, Challen R, Marlow R, et al
    Winter 2022-23 influenza vaccine effectiveness against influenza-related hospitalised aLRTD: A test-negative, case-control study.
    Vaccine. 2024 Jun 24:S0264-410X(24)00713-8. doi: 10.1016/j.vaccine.2024.

  30. LE GARS M, Sadoff J, Cardenas V, Heerwegh D, et al
    Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial.
    Vaccine. 2024 Jun 24:S0264-410X(24)00401-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  31. LIN M, Deng JZ, Scapin G, Yuan Y, et al
    Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods.
    Vaccine. 2024 Jun 24:S0264-410X(24)00709-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  32. HELARY A, Botelho-Nevers E, Bonneton M, Khennouf L, et al
    Factors, motivations and barriers associated with eagerness to volunteer in COVID-19 vaccine clinical trials in France: A mixed-method study.
    Vaccine. 2024 Jun 22:S0264-410X(24)00662-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  33. FITZPATRICK T, Yamoah P, Lacuesta G, Sadarangani M, et al
    Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study.
    Vaccine. 2024 Jun 22:S0264-410X(24)00719-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  34. CHU X, Ge S, Zuo Y, Cui J, et al
    Thoughts on the research of African swine fever live-attenuated vaccines.
    Vaccine. 2024 Jun 20:S0264-410X(24)00693-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  35. PISCHEL L, Martini BA, Yu N, Cacesse D, et al
    Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis.
    Vaccine. 2024 Jun 20:S0264-410X(24)00694-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  36. RIMAL RN, Ganjoo R, Jamison A, Parida M, et al
    Social norms, vaccine confidence, and interpersonal communication as predictors of vaccination intentions: Findings from slum areas in Varanasi, India.
    Vaccine. 2024 Jun 21:S0264-410X(24)00666-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


  37. ZHANG B, Li S, Zhou J, Wang W, et al
    A novel virus-like particles vaccine induces broad immune protective against deltacoronavirus in piglets.
    Virology. 2024;597:110150.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.